MedPath

Desoxyn

Desoxyn

Approved
Approval ID

81bfc45f-c345-47d0-9fc9-77abe553b541

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 8, 2022

Manufacturers
FDA

Key Therapeutics

DUNS: 080318791

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

methamphetamine hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code70868-820
Application NumberNDA005378
Product Classification
M
Marketing Category
C73594
G
Generic Name
methamphetamine hydrochloride
Product Specifications
Route of AdministrationORAL
Effective DateSeptember 7, 2022
FDA Product Classification

INGREDIENTS (6)

STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
LACTOSE, UNSPECIFIED FORMInactive
Code: J2B2A4N98G
Classification: IACT
METHAMPHETAMINE HYDROCHLORIDEActive
Quantity: 5 mg in 1 1
Code: 997F43Z9CV
Classification: ACTIB
AMINOBENZOATE SODIUMInactive
Code: 75UI7QUZ5J
Classification: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.